AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN NON-HODGKINS-LYMPHOMAS - PREDICTION OF MONONUCLEAR CELL YIELD IN BONE-MARROW HARVESTS

被引:0
|
作者
RINALDI, C
SAVIGNANO, C
SILVESTRI, F
GEROMIN, A
CERNO, M
FANIN, R
BIFFONI, F
BACCARANI, M
机构
[1] UNIV UDINE HOSP,DEPT BONE MARROW TRANSPLANT,DIV HEMATOL,I-33100 UDINE,ITALY
[2] GEN HOSP,UDINE,ITALY
关键词
MONONUCLEAR CELL YIELD; BONE MARROW HARVEST; NHL; ABMT;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We retrospectively analyzed the actors influencing the mononuclear cell (MNC) yield of bone marrow (BM) harvests in a cohort of 15 non-Hodgkin's lymphoma patients undergoing autologous bone marrow transplantation. All the patients were treated with the F-MACHOP regimen and four of them also received radiotherapy on bulky disease. Before harvesting, the patients underwent complete peripheral blood (PB) count, BM biopsy and aspirate. WBC and MNC/mu L were determined on the pre-harvest PB and BM aspirate samples using an automated counter. The following variables were examined in univariate and multivariate regression analysis for possible influence on the MNC yield in the harvests: age, sex, number of cycles of CT, previous radiotherapy, state of the disease at the time of harvest, interval between the end of therapy and BM harvest, cellularity of the BM biopsy, absolute WBC and MNC counts in the PB before harvesting, absolute WBC and MNC counts in the BM aspirate performed before harvesting. The amount of marrow harvested was constant for all patients: 21.2 +/- 0.24 mL/kg B.W. Among the factors analyzed, two correlated strongly with the MNC yield/kg E.W. in the harvests: the MNC count in pre-harvest PB (r = 0.823; p = 0.0001) and the MNC count in pre-harvest BM aspirate (r = 0.802; p = 0.0003). A regression equation was generated that allows calculation of the MNC/kg yield prior to harvesting.
引用
收藏
页码:443 / 447
页数:5
相关论文
共 50 条
  • [31] AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    不详
    LANCET, 1987, 1 (8528): : 303 - 304
  • [32] AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    SANTOS, GW
    YEAGER, AM
    JONES, RJ
    ANNUAL REVIEW OF MEDICINE, 1989, 40 : 99 - 112
  • [33] AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    NETZEL, B
    HAAS, RJ
    RODT, H
    KLINISCHE PADIATRIE, 1981, 193 (03): : 279 - 283
  • [34] INVIVO AND INVITRO PURGING OF BONE-MARROW IN AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    DELRE, GPB
    BONE MARROW TRANSPLANTATION, 1987, 2 : 123 - 123
  • [36] MARROW PURGING FOR AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    COMBARET, V
    FAVROT, MC
    PHILIP, T
    COVALENTLY MODIFIED ANTIGENS AND ANTIBODIES IN DIAGNOSIS AND THERAPY, 1989, 2 : 137 - 154
  • [37] IMPORTANCE OF BONE-MARROW CELL DOSE IN BONE-MARROW TRANSPLANTATION
    PAULIN, T
    CLINICAL TRANSPLANTATION, 1992, 6 (01) : 48 - 54
  • [38] SECOND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN HODGKINS-DISEASE
    AVALOS, BR
    COPELAN, EA
    BONE MARROW TRANSPLANTATION, 1993, 12 (06) : 665 - 667
  • [39] ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR RECURRENCE OF LEUKEMIA AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    SCHWELLA, N
    SCHWERDTFEGER, R
    KONIG, V
    BLASCZYK, R
    SCHMID, H
    SCHMIDTWOLF, I
    HENZE, G
    SIEGERT, W
    TRANSPLANTATION, 1994, 57 (08) : 1263 - 1265
  • [40] INDICATIONS FOR AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN HODGKINS-DISEASE
    CARELLA, AM
    LEUKEMIA & LYMPHOMA, 1992, 7 : 21 - 22